Login
Login

APHRC Online Microdata Library
  • Home
  • About APHRC
  • Datasets
  • Collections
  • Citations
  • Resources
  • How to use it?
  • Why sharing data?
  • Contact us
    Home / Central Data Catalog / HEALTH_AND_WELL-BEING / DDI-KEN-APHRC-GEGO-2021-V1.0 / variable [V117]
Health_and_Well-Being

Healthcare and Socio-economic Impacts of COVID-19 on Patients with Diabetes in Selected Counties in Kenya, GECO-Kenya

Kenya, , 2021 - 2023
Health and Well-Being (HaW)
Gershim Asiki,MD,Phd
Last modified November 26, 2024 Page views 38628 Documentation in PDF Metadata DDI/XML JSON
  • Study description
  • Documentation
  • Data Description
  • Get Microdata
  • Data files
  • GECO_FinalData1
CSV JSON

(ii) Dose (b) Number of tablets)/mg? (q3p8a2b)

Data file: GECO_FinalData1

Overview

vald 483
Interval discrete

Questions and instructions

Literal question
Think about the 3 months before [pre-COVID]. i.e between Jan and March 2020. Please indicate medication's:
Fikiria kuhusu miezi 3 kabla ya [COVID], kisha ueleze;
(b)Dose (e.g. Mls if insulin or number of tablets)
Kipimo (k.m. Mls ikiwa insulini au idadi ya vidonge)
Categories
Value Category Cases
0 46
16.7%
1 29
10.5%
1 (850mg) 1
1 a day 1
1 each 1
1 glucophage,2nogluc morning and evening 1
1 morning and 1 evening 3
1 morning and 1evening 1
1 morning and 2 evening 2
1 morning, 1 at noon and 1 evening 1
1 morning, 1 noon and 1evening 1
1 tablet 1
1(500mg) 1
1(morning 500mg) 1
1evening 2
1glucomet afternoon,1nogluc evening 1
1glucomet,1nogluc 1
1glucophage 500mg morning and evening,2nogluc morning,1nogluc evening 1
1metformin,1nogluc morning and evening 1
1mg 2
1morning 2
1morning and 1 1
1morning and 1evening 4
1morning and 2 evening 1
1tablet morning and 1tablet evening 1
1x1 9
1x2 17
1x2 glucofej, 1x1 dyamacron 1x1 poday 1
1x2, 1x1 2
1×1 1
2 118
42.8%
2 (500mg) morning ,1 noon and 1 (500mg) evening 1
2 glucomet, 1nogluc morning and evening 1
2 glucophage,1glucomet morning and evening 1
2 in the morning,2 in the evening 1
2 morning (500mg)and 1 evening (500mg) 1
2 morning and 2 evening 1
2 morning and 1 evening 3
2 morning and 1evening 1
2 morning and 2 evening 11
2 morning and 3 evening 3
2 morning and evening 2 1
2 tablets 4
2 tablets metformin, 1 tablet Glibenclamide 1
2Glocophage 1 glimepiride 1
2Glucomet,1nogluc morning and evening 1
2glucoment 1nogluc morning 1
2glucoment 1nogluc morning and evening 1
2glucoment and 1nogluc 1
2glucoment,2nogluc morning and evening 4
2glucophage 500mg,2nogluc 1
2metformin evening and morning, 1nogluc evening 1
2mg 20
2tablets 1
2x2 3
2x2 , 1x1 1
2x2, 1x1 1
3 26
9.4%
3 in the morning and 3 in the evening 1
3 morning and 2 evening 1
3.5 1
0.4%
3mg 7
3ml 1
4 43
15.6%
4 glucowel,2nogluc 1
4 morning and 3 evening 1
4glucoment,1nogluc 1
4mg 8
4tablet 1
5 5
1.8%
500mg 2
500mg metformin, 1 tablet Glibenclamide 1
6 7
2.5%
6mg 6
7 1
0.4%
9 tablets; Glucomet (2 tablets three times a day) (Norgluc 2 tablet morning & 1 tablets in the evening) 1
Glucment 1×1, Norgluc 1x1 1
Glucment 500g 1x2 1
Glucment 1000g 1
Glucment 100g 1x2 Norgluc 1x2 1
Glucment 1x1, Norgluc 1x1 1
Glucment 1x1, Norgluc 1x1 2
Glucment 1x2 4
Glucment 1x2, Norgluc 1x1 1
Glucment 1x2, Norgluc 1x2 3
Glucment 1×1 1
Glucment 1×2 2
Glucment 1×2 Nogluc2×2 Metformin 1×1 1
Glucment 1×2, Norgluc 1x1, 1
Glucment 1×2, Norgluc 1x2 1
Glucment 2x1, 1
Glucment 2x1, Norgluc 2x1 1
Glucment 500g 1x2 1
Glucment 500g 1x3, Norgluc 1x2 1
Glucment2x2, Norgluc 1x1 1
Glucment500g 1x2 1
Glucment500g 1x2 1
Glucment500g 2×2 nogluc 2×1 1
Glucomet 1 morning and 1 evening, Nogluec once day 1
Glucophage 500mg 2 tablets 1
Img 1
Metamorphin 1000g 1×2 1
Metformin 1×2, Norgluc 1x2 1
Metformin 1x2, Glinede 1x2 1
Metformin 1x2, Norgluc 1x2 1
Metformin 2 Norgluc 1 1
Metformin 500mg, Glibenclamide 1 tablet 1
Noglu1 glucment 1 1
Nogluc 1, Glucment 2 1
Nogluc2 tablets, Glucment 2 1
Norgluc 1 tablet, Glucment 1 tablet 1
Norgluc 1 tablet, Glucophage 2 tablets 1
Norgluc 1×2, Glucment 500g 1×2 1
Norgluc 2 morning, Glucment 850g one in the morning 1
Rosavel 1x1, Glucment 2x1, Metformin 850g 1x2 1
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Question pretext
Medications
[PRE-COVID] period = before March 2020
Question post text
N/A
Interviewer instructions
N/A

Description

Text
The question was asked to patients with type 2 diabetes to indicate the number of tablets they used during the three months before the COVID-19 pandemic, specifically between January and March 2020.
Universe
Patients with type 2 diabetes

others

Notes
"(ii) Dose (b) Number of tablets)/mg?"
APHRC Microdata Portal

© APHRC Microdata Portal, All Rights Reserved. Slot Online